Bicifadine

DRUG5 trials

Sponsors

DOV Pharmaceutical, Inc., XTL Biopharmaceuticals

Conditions

Chronic Low Back PainChronic Peripheral Neuropathy Pain in DiabeticsDiabetic Peripheral Neuropathy

Phase 2

Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes

XTL BiopharmaceuticalsDiabetic Peripheral Neuropathy

Start: 2007-09-30End: 2008-12-31Target: 336Updated: 2007-11-05

A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

TerminatedNCT00597649

XTL BiopharmaceuticalsChronic Peripheral Neuropathy Pain in Diabetics

Start: 2007-10-31End: 2008-12-31Target: 250Updated: 2009-06-30

Phase 3

Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain

CompletedNCT00281645

DOV Pharmaceutical, Inc.Chronic Low Back Pain

Start: 2004-12-31Target: 1250Updated: 2007-03-27

Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain

CompletedNCT00295711

DOV Pharmaceutical, Inc.Chronic Low Back Pain

Start: 2004-09-30Target: 532Updated: 2006-06-23

Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain

CompletedNCT00295724

DOV Pharmaceutical, Inc.Chronic Low Back Pain

Start: 2005-10-31Updated: 2007-01-30